Close Menu

NEW YORK (360Dx) – Ortho Clinical Diagnostics announced today that it has signed an international distribution and copromotion agreement covering 14 assays with Thermo Fisher Scientific.

Under the terms of the deal, the companies will deliver assays for monitoring therapeutics, immunosuppressants, and drugs of abuse to hospitals, hospital networks, and labs that use Ortho's Vitros 4600 chemistry system and Vitros 5600 integrated system. The assays will initially be launched in North America, Europe, Africa, and the Middle East.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Feb
23
Sponsored by
Thermo Fisher Scientific

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before. 

Feb
24
Sponsored by
SCHOTT MINIFAB

Developing a fully integrated consumable cartridge for an automated diagnostic platform is a significant challenge. More challenging still is developing such a cartridge in response to a deadly global virus pandemic amid market uncertainty and extraordinary time constraints.